Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
This study was conducted to evaluate the safety and tolerance of desloratadine after 5 weeks of repetitive dosing in children ages 2 to 12 years old with allergic hypersensitivity or chronic hives. All of the subjects enrolled in this trial were previously identified in an earlier trial to be poor metabolizers of desloratadine.
Epistemonikos ID: 6c55a81ffb91285eb734b97d66bb71e167be85d8
First added on: Dec 01, 2021